Discovery and Characterization of Zilurgisertib, a Potent and Selective Inhibitor of Activin Receptor-like Kinase-2 (ALK2) for the Treatment of Fibrodysplasia Ossificans Progressiva
用户6X7Ch8WUQ_gI
1个月前
46
10
已完结
1. 系统已在2025-11-08 09:21:50对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1021/acsmedchemlett.5c00516
文献链接: https://pubs.acs.org/doi/10.1021/acsmedchemlett.5c00516
其他信息:
出版社: American Chemical Society (ACS)
作者: Thomas Ullrich; Sabine Guth; Luca Arista; Sven Weiler; Nikolaus Stiefl; Sylvie Teixeira-Fouchard; Carien Dekker; Alexandra Hinniger; Victoria Head; Michaela Kneissel; Ina Kramer
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.5c00516
